Device Leads

Selectsecure

Payments companies reported to CMS as associated with Selectsecure. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$289Kassociated payments (2023-2025)
2,289clinicians with associated payments
1company reporting

By year

2023 $118K
2024 $75K
2025 $95K

Payments reported as associated with Selectsecure, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $160K
Cardiovascular Disease $58K
Interventional Cardiology $13K
Physician Assistant $8,576
Family $7,306
Internal Medicine $6,495

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Selectsecure

These are the largest totals companies reported as associated with Selectsecure. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Manogue Asheville, NC Clinical Cardiac Electrophysiology $4,788.47
Ulrika Birgersdotter-Green San Diego, CA Clinical Cardiac Electrophysiology $3,795.33
Pugazhendhi Vijayaraman Wilkes Barre, PA Clinical Cardiac Electrophysiology $3,766.44
Daniel Lustgarten Burlington, VT Cardiovascular Disease $2,714.22
Nicole Habel Middlebury, VT Cardiovascular Disease $2,429.03
Nicolas Karam Plattsburgh, NY Clinical Cardiac Electrophysiology $2,208.05
Zachary Hale Asheville, NC Clinical Cardiac Electrophysiology $2,069.05
Brett Atwater Fairfax, VA Clinical Cardiac Electrophysiology $1,942.97
Robert Schaller Philadelphia, PA Clinical Cardiac Electrophysiology $1,725.73
Alexander Mazur Chicago, IL Clinical Cardiac Electrophysiology $1,587.10

Prescribed Selectsecure?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.